P2.15-25 NIVEX TRIAL (GECP 1605): Nivolumab in the Real World: Spanish Expanded Access Program Experience in Pretreated Advanced NSCLC Patients

Autor:	I. Gil-Bazo, Y. García, M. Guillot, Margarita Majem, R. Blanco, Enric Carcereny, F. Garicano, J. Campillo, M. Provencio, M. González Cao, Oscar Juan, Delvys Rodriguez-Abreu, R. Bernabé, F. Grau, A. Cortes
Rok vydání:	2018
Předmět:	Pulmonary and Respiratory Medicine Oncology medicine.medical_specialty business.industry Expanded access Internal medicine Medicine Nivolumab business
Zdroj:	Journal of Thoracic Oncology. 13:S827
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2018.08.1467
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::71b7e08b99bf172f16d4cfefee405a91 https://doi.org/10.1016/j.jtho.2018.08.1467 Zobrazit plný text záznamu